Published on in Vol 10, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/24969, first published .
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)

Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)

Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)

Vicki E Maltby   1, 2, 3 , BSc, PhD ;   Rodney A Lea   2, 3, 4 , BSc, PhD ;   Mastura Monif   5, 6, 7 , MD, PhD ;   Marzena J Fabis-Pedrini   8 , BSc, PhD ;   Katherine Buzzard   5, 7 , MD, PhD ;   Tomas Kalincik   7, 9 , MD, PhD ;   Allan G Kermode   8, 10 , MD ;   Bruce Taylor   11 , MD ;   Suzanne Hodgkinson   12, 13, 14 , MD, PhD ;   Pamela McCombe   15 , MD, PhD ;   Helmut Butzkueven   6, 9 , MD, PhD ;   Michael Barnett   16, 17 , MD, PhD ;   Jeannette Lechner-Scott   1, 2, 3 , MD, PhD

1 Department of Neurology, John Hunter Hospital, New Lambton Heights, Australia

2 School for Medicine and Public Health, University of Newcastle, Callaghan, Australia

3 Hunter Medical Research Institute, New Lambton Heights, Australia

4 Institute of Health and Biomedical Innovations, Genomics Research Centre, Queensland University of Technology, Kelvin Grove, Australia

5 Department of Neurosciences, Eastern Health Clinical School, Monash University, Box Hill Hospital, Melbourne, Australia

6 Department of Neurology, Alfred Health, Melbourne, Australia

7 Department of Neurology, Melbourne Multiple Sclerosis Centre, Melbourne Health, Melbourne, Australia

8 Centre for Neuromuscular and Neurological Disorders, Perron Institute for Neurological and Translational Science, University of Western Australia, Perth, Australia

9 Clinical Outcomes Research (CORe) Unit, Department of Medicine, University of Melbourne, Melbourne, Australia

10 Institute for Immunology and Infectious Disease, Murdoch University, Perth, Australia

11 Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

12 Department of Medicine, University of New South Wales, Sydney, Australia

13 Department of Neurology, Liverpool Hospital, Sydney, Australia

14 Immune Tolerance Laboratory, Ingham Institute, Sydney, Australia

15 Centre for Clinical Research, University of Queensland, Brisbane, Australia

16 Brain and Mind Centre, University of Sydney, Sydney, Australia

17 Sydney Neuroimaging Analysis Centre, Sydney, Australia

Corresponding Author:

  • Jeannette Lechner-Scott, MD, PhD
  • School for Medicine and Public Health
  • University of Newcastle
  • Medical Genetics, Hunter Medical Research Institute building
  • c/- University Drive
  • Callaghan, 2305
  • Australia
  • Phone: 61 240420286
  • Email: jeannette.lechner-scott@health.nsw.gov.au